Bellerophon Therapeutics Inc (NASDAQ:BLPH)

1.11
Delayed Data
As of 3:51pm ET
 +0.1474 / +15.31%
Today’s Change
0.67
Today|||52-Week Range
4.49
-64.19%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$10.1M

Company Description

Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.

Contact Information

Bellerophon Therapeutics, Inc.
184 Liberty Corner Road
Warren New Jersey 07059
P:(908) 574-4770
Investor Relations:

Employees

Shareholders

Mutual fund holders5.56%
Individual stakeholders29.18%
Other institutional26.20%

Top Executives

Peter FernandesChief Executive, Regulatory & Safety Officer
Parag Suresh ShahVice President-Business Operations
Nicholas LacconaSecretary, Chief Financial & Accounting Officer
Martin DekkerVice President-Engineering & Manufacturing
Edwin L. ParsleyChief Medical Officer